Preclinical Medication Development: New Targets and New Drugs. - Wikidata - wikimedia - TriplyDB

Preclinical Medication Development: New Targets and New Drugs.

Preclinical Medication Development: New Targets and New Drugs.

http://www.wikidata.org/entity/Q37059156

about

Preclinical Medication Development: New Targets and New Drugs.

http://www.wikidata.org/entity/Q37059156

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 14 May 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Preclinical Medication Development: New Targets and New Drugs.

@en

Preclinical Medication Development: New Targets and New Drugs.

@nl

type

label

Preclinical Medication Development: New Targets and New Drugs.

@en

Preclinical Medication Development: New Targets and New Drugs.

@nl

prefLabel

Preclinical Medication Development: New Targets and New Drugs.

@en

Preclinical Medication Development: New Targets and New Drugs.

@nl

P1433

Q37059156-A9FEA9F0-1A12-4142-BF5D-C146BD1FE46D

P1476

Q37059156-4E2F8E7C-C1C5-4987-B1E8-547E31CB3DB5

P2093

Q37059156-54E25A08-208D-40C1-86CD-2483761585E9

Q37059156-F89E8773-FE54-4737-8EE5-7CF8496F1F05

P2860

Q37059156-0595866C-178C-4B72-A498-72732840BC8D

Q37059156-09B6EB56-6C07-4B4B-96F7-D3FAC5A7599F

Q37059156-1086BAE5-9D05-4130-81C9-1963B792DFC4

Q37059156-13122B3E-B225-425A-B498-AFBAD4768B38

Q37059156-1550E585-56E6-4473-947E-B7828FD1112C

Q37059156-1C9C2FAA-0882-4209-8FE9-3323CBA2BE3F

Q37059156-1E8A43A9-808E-4347-B3B1-805CE6DD7FA3

Q37059156-2238DEDF-159D-4C88-A628-5C5F7AE2A144

Q37059156-235D827D-361D-4335-B346-71BB4265A181

Q37059156-326240B0-B260-4478-AAB1-36C118DF0C26

P304

Q37059156-98D2C1E8-7F29-42DC-8E4F-4ED820FFC39A

P31

Q37059156-465925ed-9a15-49d2-beaa-76c422556f39

Q37059156-B152162C-96FC-4474-9969-769013F4D831

P356

Q37059156-D109A214-2775-4C44-A6B9-83120E788E46

P433

Q37059156-779AD5C1-4426-43F2-8D8C-1B6BB6CBB7CF

P478

Q37059156-61912A15-38C6-42AE-8F89-F6DCAFD786A8

P577

Q37059156-80302111-E737-4AE2-B7A2-43259EC982E7

P698

Q37059156-CBFC0092-0C23-4B44-8509-B4BE2F8E93F9

P932

Q37059156-5235047D-F21F-498A-939B-B5069C46E142

P356

P1433

Alcoholism: Clinical and Experimental Research

P1476

Preclinical Medication Development: New Targets and New Drugs.

@en

P2093

Chelsea R Kasten

http://www.w3.org/2001/XMLSchema#string

Stephen L Boehm

http://www.w3.org/2001/XMLSchema#string

P2860

Rates and predictors of relapse after natural and treated remission from alcohol use disorders

Advances in Diagnosis and Treatment of Fetal Alcohol Spectrum Disorders: From Animal Models to Human Studies

The mechanisms of action of PPARs

Preclinical studies of alcohol binge drinking

Neural systems of reinforcement for drug addiction: from actions to habits to compulsion

PPAR Agonists: II. Fenofibrate and Tesaglitazar Alter Behaviors Related to Voluntary Alcohol Consumption

A double-blind, placebo-controlled trial assessing the efficacy of varenicline tartrate for alcohol dependence

A double-blind, placebo-controlled trial to assess the efficacy of quetiapine fumarate XR in very heavy-drinking alcohol-dependent patients

Zonisamide, topiramate, and levetiracetam: efficacy and neuropsychological effects in alcohol use disorders

The proopiomelanocortin system.

P304

1418-1424

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/ACER.13105

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

40

http://www.w3.org/2001/XMLSchema#string

P577

2016-05-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27177689

http://www.w3.org/2001/XMLSchema#string

P932

4930385

http://www.w3.org/2001/XMLSchema#string